Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer
Condition(s):Stage I Renal Cell Cancer; Stage II Renal Cell CancerLast Updated:June 9, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Stage I Renal Cell Cancer; Stage II Renal Cell CancerLast Updated:June 9, 2023Recruiting
Condition(s):Stage II Renal Cell Cancer; Stage III Renal Cell CancerLast Updated:August 15, 2022Withdrawn
Condition(s):Kidney CancerLast Updated:April 18, 2017Completed
Condition(s):Renal Cell Carcinoma; Stage I Renal Cell Cancer AJCC v8; Stage II Renal Cell Cancer AJCC v8Last Updated:December 1, 2021Withdrawn
Condition(s):Kidney CancerLast Updated:April 29, 2015Completed
Condition(s):Recurrent Renal Cell Carcinoma; Stage I Renal Cell Cancer; Stage II Renal Cell CancerLast Updated:July 7, 2020Terminated
Condition(s):Kidney CancerLast Updated:June 12, 2013Completed
Condition(s):Kidney CancerLast Updated:March 20, 2012Withdrawn
Condition(s):Recurrent Renal Cell Cancer; Stage I Renal Cell Cancer; Stage II Renal Cell CancerLast Updated:October 13, 2017Completed
Condition(s):Clear Cell Renal Cell Carcinoma; Stage I Renal Cell Cancer; Stage II Renal Cell Cancer; Stage III Renal Cell CancerLast Updated:September 12, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.